COMMUNIQUÉS West-GlobeNewswire

Kalaris and AlloVir Announce Stockholder Approval of Merger
12/03/2025
Combined company expected to trade on Nasdaq under “KLRS” after closing PALO ALTO, Calif. and LEXINGTON, Mass., March 12, 2025 (GLOBE NEWSWIRE) -- Kalaris Therapeutics, Inc. (“Kalaris”), a clinical-stage [...]
Xenon to Present at Stifel 2025 Virtual CNS Forum
12/03/2025
VANCOUVER, British Columbia and BOSTON, March 12, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering [...]
Harvard Bioscience, Inc. to Participate in Two Investor Conferences in March 2025
12/03/2025
HOLLISTON, Mass., March 12, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will [...]
Dyadic to Report 2024 Full Year Financial Results and Host Conference call on Wednesday, March 26, 2025
12/03/2025
JUPITER, Fla., March 12, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (Nasdaq: DYAI), a biotechnology company focused on the efficient large-scale manufacture of [...]
aTyr Pharma Announces Publication Demonstrating Efzofitimod’s Immunomodulatory Activity in Science Translational Medicine
12/03/2025
Peer-reviewed publication validates efzofitimod’s unique anti-inflammatory mechanism of action on macrophages through neuropilin-2 (NRP2) receptor. Scientific insights further strengthen the rationale for clinical [...]
ACTG Presents Study at CROI Demonstrating Potential of CMV-specific Antiviral Inhibitor to Improve Aging-Related Outcomes among People Living with HIV and CMV (Cytomegalovirus)
12/03/2025
LOS ANGELES, March 12, 2025 (GLOBE NEWSWIRE) -- ACTG, a global clinical trials network focused on HIV and other infectious diseases, today presented promising findings from a study exploring how treating asymptomatic [...]
ACTG Presents Important Findings from REPRIEVE at CROI 2025
12/03/2025
Presentations Address Frailty, Inflammation, Asymptomatic Heart Muscle Damage, and Mental Function LOS ANGELES, March 12, 2025 (GLOBE NEWSWIRE) -- ACTG, a global clinical trials network focused on HIV and other [...]
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
12/03/2025
Company Announcement COPENHAGEN, Denmark; March 12, 2025 – Genmab A/S (Nasdaq: GMAB) - In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, this document [...]
Bad Science Used to Support Regulations, According to the Journal of American Physicians and Surgeons
12/03/2025
TUCSON, Ariz., March 12, 2025 (GLOBE NEWSWIRE) -- Governments issue regulations with tremendous impact on the economy and on health practices. These regulations are based on published scientific research. But there is a [...]
Constitution of the Board of Directors in Genmab A/S, Grant of Restricted Stock Units to Board Members and Employees and Grant of Warrants to Employees in Genmab
12/03/2025
Company Announcement COPENHAGEN, Denmark; March 12, 2025 – Genmab A/S (Nasdaq: GMAB) Following Genmab A/S’ Annual General Meeting held on March 12, 2025, the Company’s Board of Directors met to constitute itself. Ms. [...]
MEDIA ADVISORY: Health Coalition to announce response to court rulings on Bill 7 Charter Challenge and Orchard Villa case
12/03/2025
TORONTO, March 12, 2025 (GLOBE NEWSWIRE) -- The courts have ruled on two cases impacting thousands of elderly hospital patients and long-term care residents in Ontario and the Ontario Health Coalition is holding a press [...]
EUROBIO SCIENTIFIC ÉTEND SA PRÉSENCE EN ITALIE
12/03/2025
EUROBIO SCIENTIFIC ÉTEND SA PRÉSENCE EN ITALIE Acquisition de l'unité Life Science de Voden Medical Instruments Spa Finalisation de l'acquisition de Quimark SRL Décision du fournisseur T2 Biosystems d'arrêter la [...]
EUROBIO SCIENTIFIC INCREASES ITS FOOTPRINT IN ITALY
12/03/2025
EUROBIO SCIENTIFIC INCREASES ITS FOOTPRINT IN ITALY Signing of the acquisition of Life Science unit of Voden Medical Instruments Spa Completion of the acquisition of Quimark SRL Decision of supplier T2 Biosystems to [...]
ACTG Presents Data from Mpox Study STOMP at CROI
12/03/2025
LOS ANGELES, March 12, 2025 (GLOBE NEWSWIRE) -- ACTG, a global clinical trials network focused on HIV and other infectious diseases, recently presented data demonstrating that tecovirimat did not improve mpox resolution [...]
Inaugural Global Longevity Summit Architects New Horizons In Human Health Potential
12/03/2025
Informa Connect Medical Division announces landmark Geneva-based conference, convening the world's foremost industry leaders to forge strategic partnerships, accelerate breakthroughs, and fuse science, capital, and [...]
Passing of Genmab A/S’ Annual General Meeting
12/03/2025
Company Announcement At Genmab A/S’ Annual General Meeting held today March 12, 2025, the Annual Report for 2024 was approved Discharge was given to the Board of Directors and the Executive Management and the year’s [...]
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
12/03/2025
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS 12 March 2025 at 16.15 EET Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion [...]
Bioxytran Develops a Groundbreaking Treatment to Combat Bird Flu in Egg Laying Chickens Potentially Saving Billions
12/03/2025
New water-soluble galectin antagonist being considered in preclinical trials offering hope for rapid containment to H5N1 outbreaks BOSTON, MASSACHUSETTS, March 12, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT [...]
Shuttle Pharma Announces Pricing of $5.75 Million Underwritten Offering
12/03/2025
GAITHERSBURG, Md., March 12, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company focused on improving [...]

Pages